HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GDF-15 alleviates diabetic nephropathy via inhibiting NEDD4L-mediated IKK/NF-κB signalling pathways.

Abstract
Podocyte inflammatory injury has been indicated to play a pivotal role in the occurrence and development of diabetic nephropathy (DN). However, the pathogenesis of inflammation remains unclear. Recent researches have shown that GDF-15, a member of the transforming growth factor-β superfamily, were elevated under pathological conditions, such as myocardial ischemia, cancer, as well as inflammation. Here, we demonstrated that GDF-15 could alleviate podocyte inflammatory injury by modulating the NF-κB pathway. GDF-15 and other pro-inflammatory factors, such as TNF-α, IL-1β, and IL-6 were upregulated in the serum of HFD/STZ rat models. GDF-15 was also elevated in diabetic glomeruli and hyperglycemic stimuli treated-podocytes. The silence of GDF-15 in HG-stimulated podocytes further augmented inflammation and podocyte injury, while overexpression of GDF-15 significantly reduced the inflammatory response in podocytes. Mechanistically, we demonstrated that GDF-15 could inhibit the nuclear translocation of NF-κB through IKK and IκBα by interaction with ubiquitin ligase NEDD4L. Taken together, our data suggested a protective mechanism of elevated GDF-15 in DN through obstruction of ubiquitin degradation of IKK by inhibiting NEDD4L expression, thus decreasing the activation of NF-κB and relieving the inflammation. GDF-15 could serve as a potential therapeutic target for DN.
AuthorsXinyu Zhang, Simeng Wang, Nannan Chong, Dandan Chen, Jianqiang Shu, Jingshu Sun, Zhikang Sun, Rong Wang, Qinglian Wang, Ying Xu
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 128 Pg. 111427 (Feb 15 2024) ISSN: 1878-1705 [Electronic] Netherlands
PMID38181673 (Publication Type: Journal Article)
CopyrightCopyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.
Chemical References
  • Growth Differentiation Factor 15
  • NF-kappa B
  • Ubiquitins
Topics
  • Animals
  • Rats
  • Diabetic Nephropathies (drug therapy, metabolism)
  • Growth Differentiation Factor 15 (metabolism)
  • Inflammation (metabolism)
  • NF-kappa B (metabolism)
  • Podocytes (metabolism)
  • Ubiquitins (metabolism, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: